FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311153003> ?p ?o ?g. }

• W4311153003 endingPage "124" @default.
• W4311153003 startingPage "117" @default.
• W4311153003 abstract "Ceftiofur is a third-generation cephalosporin used in veterinary medicine to treat infections caused by gram-negative and gram-positive bacteria. It is most often used in the form of suspensions for injections based on a lipid matrix, since the active substance is poorly soluble in water. The analysis of such a drug by direct spectrophotometry is difficult due to the components of the matrix, therefore it is proposed to develop a high-performance liquid chromatography method with UV detection.&#x0D; The aim of the work was to develop a method of identification and quantitative determination of ceftiofur hydrochloride in suspensions for injections. The method was developed and validated according to the indicators of selectivity, robustness, linearity and suitability parameters of the chromatographic system. Suspension for injections containing ceftiofur 50 mg/ml was used as a sample-object for method development. The standard sample and the test sample were dissolved in the mobile phase to a concentration of 50 μg/ml. The total uncertainty of the analysis was 1.62%, which is within the limits recommended in DFU 2.0. The samples were separated on a Dionex Ultimate 3000 chromatograph equipped with a Kinetex C18-XB 150×4.6, 5 μm chromatographic column. The mobile phase was a mixture of acetonitrile and 0.05 M ammonium acetate, 0.01 M tetrabutylammonium bromide with a pH of 6.8, titrated with acetic acid, in a volume ratio of 3:7. Ceftiofur hydrochloride was detected spectrophotometrically at a wavelength of 290 nm.&#x0D; Under the above conditions, it was possible to completely separate ceftiofur (retention time of the chromatographic peak – 4.4 min) and other components of the studied drug. At the same time, the suitability parameters of the chromatographic system did not exceed the limits specified in the recommendations of the USA Food and Drug Association. For the ceftiofur hydrochloride peak, the efficiency of the chromatographic system was 13,900 theoretical plates. The relative standard deviation (RSD) for the peak areas of the active substance was ±0.11 %, and the peak separation coefficient (RS) of ceftiofur hydrochloride from other components of the drug was 17.3. The symmetry coefficient of the peak was 1.02. The calibration curves were linear in the recommended DFU 2.0 range (80–120% of the nominal concentration of the corresponding active substance). The coefficient of linearity (R2) for the peak area of ceftiofur hydrochloride was 0.9992." @default.
• W4311153003 created "2022-12-23" @default.
• W4311153003 creator A5007013648 @default.
• W4311153003 creator A5057991690 @default.
• W4311153003 creator A5065114411 @default.
• W4311153003 date "2022-12-02" @default.
• W4311153003 modified "2023-10-18" @default.
• W4311153003 title "DEVELOPMENT AND VALIDATION OF HPLC-METHOD DETERMINING QUANTITATIVE CONTENT OF CEFTIOFUR HYDROCHLORIDE IN SUSPENSIONS FOR INJECTION" @default.
• W4311153003 cites W2966291784 @default.
• W4311153003 cites W2981654199 @default.
• W4311153003 cites W4225567889 @default.
• W4311153003 cites W4226136278 @default.
• W4311153003 cites W4311153005 @default.
• W4311153003 doi "https://doi.org/10.36359/scivp.2022-23-1.17" @default.
• W4311153003 hasPublicationYear "2022" @default.
• W4311153003 type Work @default.
• W4311153003 citedByCount "0" @default.
• W4311153003 crossrefType "journal-article" @default.
• W4311153003 hasAuthorship W4311153003A5007013648 @default.
• W4311153003 hasAuthorship W4311153003A5057991690 @default.
• W4311153003 hasAuthorship W4311153003A5065114411 @default.
• W4311153003 hasBestOaLocation W43111530031 @default.
• W4311153003 hasConcept C119128265 @default.
• W4311153003 hasConcept C179998833 @default.
• W4311153003 hasConcept C185592680 @default.
• W4311153003 hasConcept C2778240358 @default.
• W4311153003 hasConcept C2780122547 @default.
• W4311153003 hasConcept C2780782300 @default.
• W4311153003 hasConcept C43617362 @default.
• W4311153003 hasConcept C501593827 @default.
• W4311153003 hasConcept C55493867 @default.
• W4311153003 hasConcept C64778159 @default.
• W4311153003 hasConceptScore W4311153003C119128265 @default.
• W4311153003 hasConceptScore W4311153003C179998833 @default.
• W4311153003 hasConceptScore W4311153003C185592680 @default.
• W4311153003 hasConceptScore W4311153003C2778240358 @default.
• W4311153003 hasConceptScore W4311153003C2780122547 @default.
• W4311153003 hasConceptScore W4311153003C2780782300 @default.
• W4311153003 hasConceptScore W4311153003C43617362 @default.
• W4311153003 hasConceptScore W4311153003C501593827 @default.
• W4311153003 hasConceptScore W4311153003C55493867 @default.
• W4311153003 hasConceptScore W4311153003C64778159 @default.
• W4311153003 hasIssue "1" @default.
• W4311153003 hasLocation W43111530031 @default.
• W4311153003 hasOpenAccess W4311153003 @default.
• W4311153003 hasPrimaryLocation W43111530031 @default.
• W4311153003 hasRelatedWork W1603333022 @default.
• W4311153003 hasRelatedWork W1964259887 @default.
• W4311153003 hasRelatedWork W1998279148 @default.
• W4311153003 hasRelatedWork W2013299392 @default.
• W4311153003 hasRelatedWork W2032191029 @default.
• W4311153003 hasRelatedWork W2084062459 @default.
• W4311153003 hasRelatedWork W2096641431 @default.
• W4311153003 hasRelatedWork W2155596957 @default.
• W4311153003 hasRelatedWork W2382440586 @default.
• W4311153003 hasRelatedWork W2393257291 @default.
• W4311153003 hasVolume "23" @default.
• W4311153003 isParatext "false" @default.
• W4311153003 isRetracted "false" @default.
• W4311153003 workType "article" @default.